ArticleBMC ophthalmology2026

Reactivation of retinopathy of prematurity after intravitreal bevacizumab: incidence, risk factors, and retreatment requirements.

Cengiz Gül et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.